Results 21 to 30 of about 359,969 (268)

Benign prostatic hyperplasia: management [PDF]

, 2012
Men with benign prostatic hyperplasia often experience lower urinary tract symptoms, the severity of which will determine treatment — options include lifestyle interventions, medication and ...
Todd, A, Husband, A
core   +3 more sources

MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY [PDF]

Zagazig University Medical Journal, 2018
Background: Benign  prostatic hyperplasia (BPH)  is a noncancerous increase of  the size of the prostate gland. The two main medication classes for BPH management are alpha blockers  and 5α -reductase inhibitors .Urinary bladder stones account for 5% of ...
Abraheem Ali, Mohammed Seleem, Ahmed Ali, Mohammed Mohammed   +3 more
doaj   +1 more source

Cystic benign prostatic hyperplasia in a dog [PDF]

, 2015
Old intact male dogs are often predisposed to benign prostatic hyperplasia. Both hypertrophy and hyperplasia of prostate gland occur due to hormonal influences.
Husna Zayadi
core   +4 more sources

Number of suicide death and suicide rates in patients diagnosed with benign prostatic hyperplasia and general population without benign prostatic hyperplasia.

, 2022
Number of suicide death and suicide rates in patients diagnosed with benign prostatic hyperplasia and general population without benign prostatic hyperplasia.
In-Hwan Oh (680029), Sang-Uk Lee (3829876), Ah-Hyun So (12225106), Jong-Ik Park (12225109), Soojung Lee (846975), Chang-Mo Oh (292091), Sang Hyub Lee (5047862)   +6 more
core   +1 more source

TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT

Arta Medica, 2021
Objectives. The aim of the study was to analyze evidence based data from existing sources, regarding the role and the efficacy of transurethral Thulium:YAG laser vapoenucleation in benign prostatic hyperplasia treatment. Material and methods.
Alexei Pleșacov, Ivan Vladanov, Vitalii Ghicavîi   +2 more
doaj   +3 more sources

Studies on Chromatographic Fingerprint and Fingerprinting Profile-Efficacy Relationship of Saxifraga stolonifera Meerb.

Molecules, 2015
This work investigated the spectrum-effect relationships between high performance liquid chromatography (HPLC) fingerprints and the anti-benign prostatic hyperplasia activities of aqueous extracts from Saxifraga stolonifera.
Xing-Dong Wu, Hua-Guo Chen, Xin Zhou, Ya Huang, En-Ming Hu, Zheng-Meng Jiang, Chao Zhao, Xiao-Jian Gong, Qing-Fang Deng   +8 more
doaj   +1 more source

Silodosin in the treatment of benign prostatic hyperplasia. [PDF]

, 2010
Benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) are highly prevalent in older men. Medical therapy is the first-line treatment for LUTS due to BPH.
Rossi, Maxime, Maxime Rossi, null Maxime Rossi, Roumeguere, Thierry, Thierry Roumeguère, Thierry Roumeguere   +5 more
core   +1 more source

Quantitation of α_1A and α_1D-adrenoceptor mRNA in prostate tissues from patients with symptomatic benign prostatic hyperplasia

Journal of Pathology of Nepal, 2011
Background: To treat symptomatic benign prostatic hyperplasia α1-adrenoceptor antagonists with little antagonism at α1b-adrenoceptor were used to avoid orthostatic hypotension.
B Acharya, H Okada, G Aryal, T Shirakawa, N Hinata, A Gotoh   +5 more
doaj   +1 more source

Portal Hypertension Secondary to Benign Prostatic Hyperplasia

, 2022
Benign prostatic hyperplasia (BPH) obstructs the bladder outlet. Patients with BPH frequently present with lower urinary tract symptoms. However, patients with BPH can present with serious fatal complications unless diagnosed and treated sufficiently. In
Emrullah Söğütdelen, Adnan Gücük, Sebahat Gücük, Mustafa Küçükyangöz   +3 more
core   +1 more source

Role of gangliosides in prostate pathology [PDF]

Romanian Journal of Infectious Diseases, 2016
Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age ...
Ilinca Nicolae, Corina-Daniela Ene, Simona Roxana Georgescu   +2 more
doaj   +1 more source